Marshall Wace’s Avita Medical RCEL Stock Holding History

Marshall Wace’s Portfolio RCEL Stock Details RCEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$194K	Buy	+52,562	New	+$221K	﹤0.01%	2796
2025 Q4	–	Sell	-42,807	Closed	-$219K	–	3393
2025 Q3	$219K	Sell	42,807 -34,018	-44%	-$177K	﹤0.01%	2546
2025 Q2	$406K	Sell	76,825 -37,267	-33%	-$271K	﹤0.01%	2213
2025 Q1	$929K	Buy	+114,092	New	+$1.07M	﹤0.01%	1816
2023 Q4	–	Sell	-13,406	Closed	-$196K	–	2534
2023 Q3	$196K	Sell	13,406 -12,094	-47%	-$205K	﹤0.01%	1978
2023 Q2	$434K	Sell	25,500 -36,215	-59%	-$531K	﹤0.01%	2031
2023 Q1	$862K	Sell	61,715 -1,759	-3%	-$18.7K	﹤0.01%	1883
2022 Q4	$419K	Buy	63,474 +48,983	+338%	+$294K	﹤0.01%	2439
2022 Q3	$77K	Buy	+14,491	New	+$89.5K	﹤0.01%	3210
2021 Q3	–	Sell	-30,828	Closed	-$633K	–	3351
2021 Q2	$633K	Buy	+30,828	New	+$608K	﹤0.01%	2025

Other funds holding RCEL

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

DSCM

Divisadero Street Capital Management Miami, Florida $2.39B AUM 134.55% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Marshall Wace's RCEL Position: Q1 2026 in Review

Marshall Wace opened a new position in Avita Medical (RCEL) in Q1 2026: 52,562 shares worth $194K. The stake represents ﹤0.01% of the portfolio and ranks #2796 among its holdings. This is a return to the name: Marshall Wace previously reported a position in RCEL as recently as Q3 2025.

Marshall Wace first reported a position in RCEL in Q2 2021 and has held it in 10 quarters since. The position peaked at $929K in Q1 2025. 79 funds tracked by Wall St. Rank hold RCEL as of Q1 2026.

Marshall Wace held 52,562 shares of Avita Medical worth $194K as of Q1 2026.
Avita Medical was a new Marshall Wace position in Q1 2026.
Avita Medical made up ﹤0.01% of Marshall Wace's portfolio in Q1 2026, its #2796 holding.
Marshall Wace first reported a position in Avita Medical in Q2 2021 and has held it in 10 quarters since.
Marshall Wace's Avita Medical position peaked at $929K in Q1 2025.
79 funds tracked by Wall St. Rank held Avita Medical as of Q1 2026.

Based on Marshall Wace's 13F filing for Q1 2026, filed 15 May 2026.